- Home
- GRI vs ANTE Comparison
GRI vs ANTE Comparison
Compare GRI & ANTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRI
- ANTE
- Stock Information
- Founded
- GRI 2018
- ANTE 2005
- Country
- GRI United States
- ANTE China
- Employees
- GRI N/A
- ANTE N/A
- Industry
- GRI Biotechnology: Pharmaceutical Preparations
- ANTE Advertising
- Sector
- GRI Health Care
- ANTE Consumer Discretionary
- Exchange
- GRI Nasdaq
- ANTE Nasdaq
- Market Cap
- GRI 6.1M
- ANTE 5.7M
- IPO Year
- GRI N/A
- ANTE N/A
- Fundamental
- Price
- GRI $0.78
- ANTE $0.42
- Analyst Decision
- GRI Strong Buy
- ANTE
- Analyst Count
- GRI 2
- ANTE 0
- Target Price
- GRI $11.50
- ANTE N/A
- AVG Volume (30 Days)
- GRI 377.5K
- ANTE 109.2K
- Earning Date
- GRI 11-14-2024
- ANTE 12-26-2024
- Dividend Yield
- GRI N/A
- ANTE N/A
- EPS Growth
- GRI N/A
- ANTE N/A
- EPS
- GRI N/A
- ANTE 2.64
- Revenue
- GRI N/A
- ANTE $500,000.00
- Revenue This Year
- GRI N/A
- ANTE N/A
- Revenue Next Year
- GRI N/A
- ANTE N/A
- P/E Ratio
- GRI N/A
- ANTE $0.16
- Revenue Growth
- GRI N/A
- ANTE N/A
- 52 Week Low
- GRI $0.30
- ANTE $0.26
- 52 Week High
- GRI $65.00
- ANTE $2.90
- Technical
- Relative Strength Index (RSI)
- GRI 49.02
- ANTE 47.27
- Support Level
- GRI $0.75
- ANTE $0.37
- Resistance Level
- GRI $1.00
- ANTE $0.46
- Average True Range (ATR)
- GRI 0.09
- ANTE 0.06
- MACD
- GRI -0.00
- ANTE -0.00
- Stochastic Oscillator
- GRI 38.93
- ANTE 46.67
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist, for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
About ANTE AirNet Technology Inc.
AirNet Technology Inc provides in-flight solutions to connectivity, entertainment, and digital multimedia in China. It offers Internet connections through a network of satellites and land-based beacons, provides airline travelers with interactive entertainment, and breaking news, and furnishes corporate clients with advertisements tailored to the perceptions of the travelers. The revenues are mainly derived from selling advertising time slots on the companies advertising networks and cryptocurrency mining.